SkyDance Vascular

SkyDance Vascular, Inc., founded in 2017, is a medical device company focused on redesigning the peripheral intravenous catheter (PIVC) to address common complications in vascular access. The company was founded by Michael Anstett, a Registered Nurse with a vascular access board certification (VA-BC), who now serves as the Chief Clinical Officer. His clinical background and experience in vascular access directly inform the company's approach to product development. SkyDance Vascular operates in the medical supplies market, providing its products to healthcare professionals and facilities. The business model centers on the development, manufacturing, and sale of these proprietary catheter systems.

The company's flagship product line is the OspreyIV Catheter System, which has received multiple 510(k) clearances from the U.S. Food and Drug Administration (FDA). Unlike traditional over-the-needle catheters, the OspreyIV features a through-the-needle deployment method. This design ensures the catheter does not contact the patient's skin upon insertion, a feature termed Skin Avoidance Technology, which is intended to reduce the risk of contamination and subsequent infections. Additional features include a passive needle retraction system to prevent needlestick injuries, a "Bevel Only Technique" to minimize vessel trauma, and a contoured directional flow tip designed to deliver fluids more efficiently and lower the risks of phlebitis and infiltration. The product family includes a peripheral IV catheter system, a closed IV catheter system, and a midline closed IV catheter system for extended dwell times. The company has secured significant seed funding to support growth, expand its intellectual property portfolio, and facilitate commercial launch efforts.

The executive team is composed of industry veterans with extensive experience in the vascular access space at companies like C.R. Bard, Med-Comp, B. Braun, and Covidien. This leadership group has a track record of developing and commercializing medical devices, as well as successfully scaling and selling startup businesses in the same sector. As of May 2025, SkyDance has received FDA clearance for its Osprey Midline Closed IV Catheter System, building upon previous clearances for its OspreyF20 and OspreyV2-F20 catheters. The company is headquartered in Delray Beach, Florida, with additional operations in Utah. Keywords: vascular access, peripheral intravenous catheter, PIVC, catheter technology, medical device, through-the-needle catheter, infection prevention, needlestick safety, phlebitis reduction, OspreyIV, extended dwell catheter, midline catheter, intravenous therapy, catheter delivery system, medical supplies, infusion therapy, vessel preservation, sharps safety, catheter-related complications, FDA 510(k) clearance